Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Existing investors provide funding to finish international RESPONDER-HF trial

Funding round allows completion of RESPONDER-HF trial of Corvia atrial shunt - Cardiovascular News

Corvia Atrial Shunt Corvia Medical has announced the successful closure of a US$55 million funding round with funds to be used to complete the ongoing RESPONDER-HF, double-blinded, randomised, sham-controlled, confirmatory trial of the Corvia atrial shunt. The study, which is currently underway at more than 65 institutions on three continents, is expected to generate the final supportive clinical data required for US Food and Drug Administration…

Corvia Medical raises $55m to complete confirmatory heart shunt trial

Corvia Medical has raised $55m to complete an ongoing clinical trial of its atrial shunt system for heart failure.The post Corvia Medical raises $55m to complete confirmatory heart shunt trial appeared first on Medical Device Network.